UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Activation of the Nitric Oxide Synthase 2 Pathway in the Response of Bone Marrow Stromal Cells to High Doses of Ionizing Radiation

Radiation research, 2000-07, Vol.154 (1), p.73-86

2000

Volltextzugriff (PDF)

The role of intracisternal A-type particles in the evolution of factor-independent murine hematopoietic cell lines

Leukemia, 1998, Vol.12 (1), p.4-12

1998

Volltextzugriff (PDF)

A CF modifier means meconium in mouse and man

Gastroenterology (New York, N.Y. 1943), 2000-07, Vol.119 (1), p.268-269

2000

Volltextzugriff (PDF)

Pancreatitis as a risk for pancreatic cancer

Gastroenterology Clinics of North America, 2002-06, Vol.31 (2), p.663-678

2002

Volltextzugriff (PDF)

2MO Development of a prognostic gene-expression signature for early stage HER2-positive breast cancer patients

Annals of oncology, 2022-05, Vol.33, p.S124-S124

2022

Volltextzugriff (PDF)

Abstract PD3-02: Incidence of late relapse in HER2-positive (HER2+) breast cancer patients receiving adjuvant trastuzumab: Combined analysis of NCCTG (Alliance) N9831 and NSABP (NRG) B31

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.PD3-02-PD3-02

2019

Volltextzugriff (PDF)

Effect of the irradiated microenvironment on the expression and retrotransposition of intracisternal type A particles in hematopoietic cells

Experimental hematology, 2000-06, Vol.28 (6), p.680-689

2000

Volltextzugriff (PDF)

166PAnalysis of circulating tumour DNA for early relapse detection in stage III colorectal cancer after adjuvant chemotherapy

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Abstract GS3-02: PALLET: A neoadjuvant study to compare the clinical and antiproliferative effects of letrozole with and without palbociclib

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.GS3-02-GS3-02

2019

Volltextzugriff (PDF)

Enhanced rate of conversion or recombination of markers within a region of unique sequence in the herpes simplex virus genome

Journal of Virology, 1986-05, Vol.58 (2), p.704-708

1986

Volltextzugriff (PDF)

The single base pair substitution responsible for the syn phenotype of herpes simplex virus type 1, strain MP

Virology (New York, N.Y.), 1987-03, Vol.157 (1), p.67-74

1987

Volltextzugriff (PDF)

Abstract PD3-18: The NSABP/NRG 8-gene signature accurately predicts degree of benefit from trastuzumab in Alliance/NCCTG N9831: Validation of the 8-gene signature in an independent clinical trial

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.PD3-18-PD3-18

2018

Volltextzugriff (PDF)

Novel rearrangements of herpes simplex virus DNA sequences resulting from duplication of a sequence within the unique region of the L component

Journal of Virology, 1985-02, Vol.53 (2), p.456-461

1985

Volltextzugriff (PDF)

Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group

NPJ breast cancer, 2020-05, Vol.6 (1), p.16, Article 16

2020

Volltextzugriff (PDF)

Abstract P3-10-04: The fully validated NSABP/NRG 8-gene signature which predicted the degree of benefit in the adjuvant setting (B-31 and NCCTG N9831) associates with pCR in the neoadjuvant setting in NSABP clinical trial FB-7

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P3-P3-10-04

2019

Volltextzugriff (PDF)

Abstract PD3-04: Analysis of ERBB2 (HER2) amplification by ctDNA in a phase Ib dose-escalation trial evaluating trastuzumab emtansine (T-DM1) with neratinib in women with metastatic disease with initially diagnosed HER2+ breast cancer: NSABP FB-10

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.PD3-04-PD3-04

2019

Volltextzugriff (PDF)

Hereditary, familial, and idiopathic chronic pancreatitis are not associated with polymorphisms in the tumor necrosis factor alpha (TNF-alpha) promoter region or the TNF receptor 1 (TNFR1) gene

Genetics in medicine, 2003-03, Vol.5 (2), p.120-125

2003

Volltextzugriff (PDF)

Expression of Herpes Simplex Virus Glycoprotein C from a DNA Fragment Inserted into the Thymidine Kinase Gene of This Virus

Proceedings of the National Academy of Sciences - PNAS, 1982-11, Vol.79 (21), p.6612-6616

1982

Volltextzugriff (PDF)

Abstract P1-07-12: An exploratory correlative biomarker analysis of NSABP FB-7, a phase II randomized trial evaluating neoadjuvant therapy with weekly paclitaxel (P) plus neratinib (N) or trastuzumab (T) or neratinib and trastuzumab (N+T) followed by doxorubicin and cyclophosphamide (AC) with postoperative T in women with locally advanced HER2-positive breast cancer

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P1-P1-07-12

2017

Volltextzugriff (PDF)

Pancreatitis as a risk for pancreatic cancer

Hematology/oncology clinics of North America, 2003-04, Vol.17 (2), p.647-661

2003

Volltextzugriff (PDF)

Multigene predictors developed on breast cancer cell lines to predict patient chemotherapy response: A validation study on the NSABP B-27 trial

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.1029-1029

2011

Volltextzugriff (PDF)

P1-06-15: A Genomic Predictor Developed from Breast Cancer Cell Lines Predicts Both Disease-Free Survival and Overall Survival in Breast Cancer Patients Treated with Doxorubicin and Cyclophosphamide: A Collaborative Project of the NSABP and Precision Therapeutics

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P1-P1-06-15

2011

Volltextzugriff (PDF)

Use of a prognostic (prog) gene index and nodal status to identify a subset of stage II and III colon cancer patients (pts) who may not need oxaliplatin (ox)-containing adjuvant chemotherapy

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.3516-3516

2010

Volltextzugriff (PDF)

Identification of a second tetracycline-inducible polypeptide encoded by Tn10

Journal of Bacteriology, 1980-10, Vol.144 (1), p.346-355

1980

Volltextzugriff (PDF)

Abstract PD5-04: NSABP FB-7: A phase II randomized trial evaluating neoadjuvant therapy with weekly paclitaxel (P) plus neratinib (N) or trastuzumab (T) or neratinib and trastuzumab (N+T) followed by doxorubicin and cyclophosphamide (AC) with postoperative T in women with locally advanced HER2-positive breast cancer

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.PD5-04-PD5-04

2016

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Aktive Filter

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(47)

Sprache

Englisch
(47)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(23)
Science & Technology
(23)
Humans
(12)
Base Sequence
(9)
Animals
(8)
Biological And Medical Sciences
(8)
Fundamental And Applied Biological Sciences. Psychology
(8)
Genetics
(7)
Microbiology
(7)
Virology
(7)
Genes, Viral
(6)
Mice
(6)
Mutation
(6)
Oncology
(6)
Herpes Simplex Virus 1
(5)
Simplexvirus - Genetics
(5)
Dna Restriction Enzymes
(4)
Dna, Viral - Genetics
(4)
Genes
(4)
Hematology
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Activation of the Nitric Oxide Synthase 2 Pathway in the Response of Bone Marrow Stromal Cells to High Doses of Ionizing Radiation

The role of intracisternal A-type particles in the evolution of factor-independent murine hematopoietic cell lines

A CF modifier means meconium in mouse and man

Pancreatitis as a risk for pancreatic cancer

2MO Development of a prognostic gene-expression signature for early stage HER2-positive breast cancer patients

Abstract PD3-02: Incidence of late relapse in HER2-positive (HER2+) breast cancer patients receiving adjuvant trastuzumab: Combined analysis of NCCTG (Alliance) N9831 and NSABP (NRG) B31

Effect of the irradiated microenvironment on the expression and retrotransposition of intracisternal type A particles in hematopoietic cells

166PAnalysis of circulating tumour DNA for early relapse detection in stage III colorectal cancer after adjuvant chemotherapy

Abstract GS3-02: PALLET: A neoadjuvant study to compare the clinical and antiproliferative effects of letrozole with and without palbociclib

Enhanced rate of conversion or recombination of markers within a region of unique sequence in the herpes simplex virus genome

The single base pair substitution responsible for the syn phenotype of herpes simplex virus type 1, strain MP

Abstract PD3-18: The NSABP/NRG 8-gene signature accurately predicts degree of benefit from trastuzumab in Alliance/NCCTG N9831: Validation of the 8-gene signature in an independent clinical trial

Novel rearrangements of herpes simplex virus DNA sequences resulting from duplication of a sequence within the unique region of the L component

Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group

Abstract P3-10-04: The fully validated NSABP/NRG 8-gene signature which predicted the degree of benefit in the adjuvant setting (B-31 and NCCTG N9831) associates with pCR in the neoadjuvant setting in NSABP clinical trial FB-7

Abstract PD3-04: Analysis of ERBB2 (HER2) amplification by ctDNA in a phase Ib dose-escalation trial evaluating trastuzumab emtansine (T-DM1) with neratinib in women with metastatic disease with initially diagnosed HER2+ breast cancer: NSABP FB-10

Hereditary, familial, and idiopathic chronic pancreatitis are not associated with polymorphisms in the tumor necrosis factor alpha (TNF-alpha) promoter region or the TNF receptor 1 (TNFR1) gene

Expression of Herpes Simplex Virus Glycoprotein C from a DNA Fragment Inserted into the Thymidine Kinase Gene of This Virus

Pancreatitis as a risk for pancreatic cancer

Multigene predictors developed on breast cancer cell lines to predict patient chemotherapy response: A validation study on the NSABP B-27 trial

P1-06-15: A Genomic Predictor Developed from Breast Cancer Cell Lines Predicts Both Disease-Free Survival and Overall Survival in Breast Cancer Patients Treated with Doxorubicin and Cyclophosphamide: A Collaborative Project of the NSABP and Precision Therapeutics

Use of a prognostic (prog) gene index and nodal status to identify a subset of stage II and III colon cancer patients (pts) who may not need oxaliplatin (ox)-containing adjuvant chemotherapy

Identification of a second tetracycline-inducible polypeptide encoded by Tn10

Aktive Filter

Suchergebnisse filtern